Novo Nordisk (NVO) is down 20% — but is this a golden buying opportunity or a financial free fall in disguise?Plus: custom buy zones for value hunters. If you're watching this stock... don’t make a move until you've seen this analysis. Not financial advice. Just brutal clarity.🔔 Subscribe for more breakdowns of falling knives, rising opportunities, and everything in between.